During the past decade, Saint Elizabeth Medical Center South conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 22 clinical trials were completed, i.e. on average, 53.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 11 clinical trials were completed. i.e. 78.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Elizabeth Medical Center South" #1 sponsor was "National Cancer Institute (NCI)" with 23 trials, followed by "Gynecologic Oncology Group" with 10 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "NRG Oncology" with 5 trials sponsored and "Abbott Medical Devices" with 5 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Elizabeth Medical Center South" #1 collaborator was "National Cancer Institute (NCI)" with 33 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 5 trials as a collaborator and "Medical University of South Carolina" with 3 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Saint Elizabeth Medical Center South" are "Recurrent Ovarian Carcinoma" (6 trials), "Endometrial Serous Adenocarcinoma" (5 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (5 trials), "Fallopian Tube Transitional Cell Carcinoma" (5 trials) and "Ovarian Seromucinous Carcinoma" (5 trials). Many other conditions were trialed in "Saint Elizabeth Medical Center South" in a lesser frequency.

Most popular intervention types in "Saint Elizabeth Medical Center South" are "Drug" (50 trials), "Other" (41 trials), "Procedure" (21 trials), "Biological" (19 trials) and "Radiation" (13 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (23 trials), "Laboratory Biomarker Analysis" (17 trials), "Carboplatin" (16 trials), "Paclitaxel" (15 trials) and "Questionnaire Administration" (15 trials). Other intervention names were less common.

The vast majority of trials in "Saint Elizabeth Medical Center South" are 36 trials for "Female" genders, 34 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Elizabeth Medical Center South". undefined are not yet recruiting, 15 are recruiting, 31 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Saint Elizabeth Medical Center South, 2 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Elizabeth Medical Center South, 4 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".

Saint Elizabeth Medical Center South has several departments that took part in Clinical trials: "St. Elizabeth Edgewood; Cancer Care Center" for Account St. Elizabeth Edgewood" - 2 trials, "Esther Marie Hatton Cancer Care Center at St. Elizabeth Medical Center" - 2 trials, "St. Elizabeth Healthcare" - 2 trials